Combination of a taxane and a cyclindependent kinase inhibitor

Details for Australian Patent Application No. 2002312815 (hide)

Owner Aventis Pharma S.A.

Inventors Bissery, Marie-Christine

Agent Watermark

Pub. Number AU-B-2002312815

PCT Number PCT/EP02/04083

PCT Pub. Number WO2002/076484

Priority 60/277,948 23.03.01 US; 60/334,916 04.12.01 US; 60/302,692 05.07.01 US

Filing date 22 March 2002

Wipo publication date 8 October 2002

Acceptance publication date 24 August 2006

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 60/277,948 23.03.01 US; 60/334,916 04.12.01 US; 60/302,692 05.07.01 US

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2002312815

24 August 2006 Application Accepted

  Published as AU-B-2002312815

21 December 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002312816-INACTIVATION OF GENES OF THE MEP PATHWAY

2002312814-METHOD FOR PRODUCING ACRYLIC ACID BY HETEROGENEOUSLY CATALYZED GAS PHASE OXIDATION OF PROPENE WITH MOLECULAR OXYGEN IN A REACTION ZONE